Toxicology evaluation of radiotracer doses of 3′-deoxy-3′- [18F]fluorothymidine (18F-FLT) for human PET imaging: Laboratory analysis of serial blood samples and comparison to previously investigated therapeutic FLT doses

BMC Nuclear Medicine

Volumn 7, Issue , 2007, Pages

  Turcotte, Eric ^a   Wiens, Linda W ^a   Grierson, John R ^a   Peterson, Lanell M ^a   Wener, Mark H ^b   Vesselle, Hubert ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' DEOXY 3' FLUOROTHYMIDINE FLUORINE 18; ALBUMIN; BILIRUBIN; HEMOGLOBIN; TRACER; UNCLASSIFIED DRUG;

ADULT; AGED; ALBUMIN BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD SAMPLING; COMPARATIVE STUDY; DYNAMICS; ERYTHROCYTE COUNT; EVALUATION; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYDRATION; INJECTION; LABORATORY TEST; MALE; POSITRON EMISSION TOMOGRAPHY; SAFETY; SIDE EFFECT; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; TOXICOLOGY;

EID: 34547120941     PISSN: None     EISSN: 14712385     Source Type: Journal    
DOI: 10.1186/1471-2385-7-3     Document Type: Article

References (18)

1. Phosphorylation, anti-HIV activity and cytotoxicity of 3'-fluorothymidine. E Matthes C Lehmann D Scholz HA Rosenthal P Langen, Biochem Biophys Res Commun 1988 153 2 825 831 10.1016/S0006-291X(88)81170-7 3164184
2. Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues. ES Arner T Spasokoukotskaja S Eriksson, Biochem Biophys Res Commun 1992 188 2 712 718 10.1016/0006-291X(92)91114-6 1359886
3. 3'-Deoxy-3'-fluorothymidine, a new selective inhibitor of DNA synthesis. P Langen G Etzold R Hintsche G Kowollick, Acta Biol Med Ger 1969 23 759 766 5375478
4. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. B Munch-Petersen L Cloos G Tyrsted S Eriksson, J Biol Chem 1991 266 14 9032 9038 2026611
5. Regulation of human thymidine kinase during the cell cycle. JL Sherley TJ Kelly, J Biol Chem 1988 263 17 8350 8358 3372530
6. Rates of Accumulation and retention of 3'-Deoxy-3'-fluorothymidine (FLT) in Different Cell Lines. JL Schwartz JR Grierson JS Rasey L Wiens R Jordan T Kohli, J Nucl Med 2001 42(5) 283P (Abstract)
7. Radiosynthesis of 3'-deoxy-3'-[(18)F]fluorothymidine: [(18)F]FLT for imaging of cellular proliferation in vivo. JR Grierson AF Shields, Nucl Med Biol 2000 27 2 143 156 10.1016/S0969-8051(99)00104-3 10773543
8. An improved synthesis [F-18]FLT. JR Grierson AF Shields, J Labelled Comp Radiopharm 1999 42 S525 S526
9. Basis of FLT as a cell proliferation marker: comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines. J Toyohara A Waki S Takamatsu Y Yonekura Y Magata Y Fujibayashi, Nucl Med Biol 2002 29 3 281 287 10.1016/S0969-8051(02)00286-X 11929696
10. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. JS Rasey JR Grierson LW Wiens PD Kolb JL Schwartz, J Nucl Med 2002 43 9 1210 1217 12215561
11. In Vivo Validation of 3'deoxy-3'-[(18)F]fluorothymidine ([(18)F]FLT) as a Proliferation Imaging Tracer in Humans: Correlation of [(18)F]FLT Uptake by Positron Emission Tomography with Ki-67 Immunohistochemistry and Flow Cytometry in Human Lung Tumors. H Vesselle J Grierson M Muzi JM Pugsley RA Schmidt P Rabinowitz LM Peterson E Vallieres DE Wood, Clin Cancer Res 2002 8 11 3315 3323 12429617
12. 3-deoxy-3-[(18)F]fluorothymidine-positron emission tomography for noninvasive assessment of proliferation in pulmonary nodules. AK Buck H Schirrmeister M Hetzel M Von Der Heide G Halter G Glatting T Mattfeldt F Liewald SN Reske B Neumaier, Cancer Res 2002 62 12 3331 3334 12067968
13. Kinetic analysis of 3'-deoxy-3'-fluorothymidine PET studies: validation studies in patients with lung cancer. M Muzi H Vesselle JR Grierson DA Mankoff RA Schmidt L Peterson JM Wells KA Krohn, J Nucl Med 2005 46 2 274 282 15695787
14. The Ki-67 index and survival in non-small cell lung cancer: a review and relevance to positron emission tomography. JM Pugsley RA Schmidt H Vesselle, Cancer J 2002 8 3 222 233 12074319
15. 18F-Fluorothymidine radiation dosimetry in human PET imaging studies. H Vesselle J Grierson LM Peterson M Muzi DA Mankoff KA Krohn, J Nucl Med 2003 44 9 1482 1488 12960196
16. Phase 1 pharmacokinetic evaluation of 3'-deoxy-3'-fluorothymidine (FLT), a new potent anti-HIV nucleoside [abstract 2114]. PA Barditch-Crovo DM Kornhauser BG Petty, VII International Conference on AIDS Florence, Italy 1991
17. Relationship between plasma concentrations of 3'-deoxy-3'-fluorothymidine (alovudine) and antiretroviral activity in two concentration-controlled trials. C Flexner C van der Horst MA Jacobson W Powderly F Duncanson D Ganes PA Barditch-Crovo BG Petty PA Baron D Armstrong, J Infect Dis 1994 170 6 1394 1403 7995977
18. Validation of PET-acquired input functions for cardiac studies. IN Weinberg SC Huang EJ Hoffman L Araujo C Nienaber M Grover-McKay M Dahlbom H Schelbert, J Nucl Med 1988 29 2 241 247 3258026